Studies of experimental hemochromatosis. Disorder of the reticuloendothelial system and excess iron.
D000596:Amino Acids / Q000494:pharmacology; D000818:Animals; D001853:Bone Marrow / Q000378:metabolism; D002951:Citrates / Q000633:toxicity; D003677:Deficiency Diseases; D006432:Hemochromatosis / Q000139:chemically induced* / Q000378:metabolism; D066298:In Vitro Techniques; D007501:Iron / Q000032:analysis / Q000378:metabolism* / Q000633:toxicity; D007503:Iron Isotopes; D008082:Lipotropic Agents; D008099:Liver / Q000378:metabolism; D008297:Male; D000432:Methanol; D012157:Mononuclear Phagocyte System / Q000503:physiopathology*; D009206:Myocardium / Q000378:metabolism; D009355:Neomycin / Q000494:pharmacology; D010179:Pancreas / Q000378:metabolism; D011687:Purines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D051381:Rats; D013154:Spleen / Q000378:metabolism; D014168:Transferrin / Q000378:metabolism; D014815:Vitamins / Q000494:pharmacology
D000596:Amino Acids; D002951:Citrates; D007503:Iron Isotopes; D008082:Lipotropic Agents; D011687:Purines; D011743:Pyrimidines; D014168:Transferrin; D014815:Vitamins; D007501:Iron; D009355:Neomycin; D000432:Methanol